Q-linea AB (publ)
Research Q-linea AB (publ) (3F80) on Bullrun: market cap EUR 30.03M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3F80
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 30.03M
- Financial periodFY2024
- RevenueSEK 2.36M
- Revenue growth-46.8%
- Net income-SEK 216.87M
- Free cash flow-SEK 187.49M
Valuation Snapshot
latest market cap is EUR 30.03M.
About Q-linea AB (publ)
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland. It offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert.
Frequently asked questions
What is Q-linea AB (publ)'s market cap?
Q-linea AB (publ)'s market capitalization is EUR 30.03M.
What does Q-linea AB (publ) do?
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland.